MedPath

A Study on Training Effect by Robot Suit HAL for Medical Use (Lower Limb Type)- Verification in patients with Parkinson's disease

Phase 2
Conditions
Parkinson's disease
Registration Number
JPRN-jRCTs042180060
Lead Sponsor
Ogawa Tetsuo
Brief Summary

In this study, the number of cases was as small as 6, and gender bias was also observed among the groups. As a result of regression analysis for TUG, UPDRS part III, FOG-Q, BBS, 10m walking speed, neither the effect size of the training using HAL nor the carry-over effect of the HAL preceding group has significant difference from that of the usual training

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
6
Inclusion Criteria

Patients diagnosed as clinically established or clinically probable Parkinson's disease with Movement Disorder Society (MDS) clinical diagnostic criteria
-Patients who meet the stage 2-4 for Hoehn & Yahr staging scale
-Patients who consent with full understanding
-Patients judged that who are stable, and able to stand and walk
-Patients with the ability to stand and walk more than 10 m without assistance
-Patients' weight: 40 to 100 kg
-Patients' heights: 150 to 190 cm

Exclusion Criteria

-Patients planned to change the dose of anti-Parkinson's disease drug
-Patients judged as inappropriate for the walking training
-Patients have difficulties with wearing HAL
-Patients have difficulties with putting the electrodes on the skin
-Patients during pregnancy
-Patients have difficulties with understanding instructions

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Timed up and Go test
Secondary Outcome Measures
NameTimeMethod
age, gender, height, weight, disease duration, HDS-R, Hoehn & Yahr staging scale, Classification according to clinical diagnostic criteria of Parkinson's disease by MDS, MDS-UPDRS part III, freezing of gait questionnaire(FOG-Q), 10m gait speed, step length, Berg Balance Scale(BBS), Video
© Copyright 2025. All Rights Reserved by MedPath